| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Aug 12, 2024 | Aug 14, 2024 | HALOZYME THERAPEUTICS, INC. | Director | Sell | 17.5 | -29,881 | -29.95% | ✗ | $1.7M |
| Jun 11, 2024 | Jun 13, 2024 | HALOZYME THERAPEUTICS, INC. | Director | Sell | 17.5 | -20,000 | -16.70% | ✗ | $1M |
| Dec 2, 2022 | Dec 6, 2022 | HALOZYME THERAPEUTICS, INC. | Director | Sell | 17.5 | -30,000 | -22.19% | ✗ | $1.7M |
| Nov 30, 2021 | Dec 1, 2021 | Nautilus Biotechnology, Inc. | Director | Buy | 95.0 | +50,000 | 50.00% | ✗ | $225.5K |